Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.38 |
| ▸ | ACP1 | P24666 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | TACR3 | P29371 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 3/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.35 |
| ▸ | HSF1 | Q00613 | 1/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17708555 | 0.90 | ADORA2A (0.39) | ADORA2AKDM4CPARP1P2RY6PDGFRB | |
| SCHEMBL863178 | 0.83 | KDR (0.39) | ADORA2AP2RY6CYP3A4KDRCDK2 | |
| SCHEMBL863311 | 0.82 | TGFBR1 (0.39) | ADORA2ACYP3A4KDRCDK2 | |
| SCHEMBL11983623 | 0.79 | CCR1 (0.57) | KDM4CP2RY6KDRCHEK1 | |
| SCHEMBL20019709 | 0.78 | PARP1 (0.44) | ADORA2AKDM4CPARP1PDGFRBBACE1 | |
| SCHEMBL29094507 | 0.76 | ADORA2A (0.38) | ADORA2AKDM4CPARP1P2RY6PDGFRB | |
| SCHEMBL3986898 | 0.75 | P2RY6 (0.33) | ADORA2AKDM4CPARP1P2RY6BACE1 | |
| SCHEMBL18051426 | 0.74 | HDAC1 (0.39) | ADORA2AKDM4CPDGFRBBACE1CDK2 | |
| SCHEMBL23416965 | 0.73 | CCR1 (0.58) | KDM4CPARP1P2RY6CYP3A4KDR | |
| SCHEMBL22940779 | 0.73 | CCR1 (0.58) | ADORA2AKDM4CPARP1PDGFRBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507679-B2 | Heteroleptic, dual tridentate Ru(II) complexes as sensitizers for dye-sensitized solar cells | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-08-13 | — | — | US | disclosed |
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | RUVBL2, RUVBL1, CCNL2 | ADORA2A 1997/4885KDM4C 3048/4885PARP1 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.